The Symposium on Clinical Interventional Oncology (CIO) will separate from the International Symposium on Endovascular Therapy (ISET) starting from next year. Beginning in 2019, ISET will shift to a four-day format and will take place 27–30 January at The Diplomat Resort (Hollywood, USA), whilst CIO will be held 11–13 October as a standalone conference at the Eden Roc Hotel (Miami Beach, USA).
HMP, a healthcare event and education charity that runs both CIO and ISET, states in a press release that this is “a move designed to proactively address the growing need for highly specialised, interactive, and practical education for today’s endovascular and vascular specialists.”
Traditionally held concurrently with ISET annually in South Florida, the CIO program highlights innovative and viable treatments in interventional oncology. HMP claim in a press release that the move to separate the meetings reflects the ever-growing importance of interventional oncology (IO), the commitment to the clinical practice of IO, and the increased demand for IO education.
According to Constantino Peña and Ripal Gandhi (both Miami, USA), long-time ISET course directors: “We are extremely proud to be leading the way in this rapidly evolving field. After 11 successful years, the course directors have found it critical to grow the meeting in order to continue our vision of innovative and practical IO education delivered by best-in-class, multidisciplinary experts in order to improve the lives of millions of patients with cancer using minimally invasive techniques. By creating a dedicated CIO event, we will have the opportunity to expand the focus on clinical content, accommodate new attendees, and continue to train the next generation of physicians in this growing field.”
ISET’s hallmark Live Cases, representing the practical core of the meeting, will be expanded to include an additional 90 minutes of case time. Cases will transmit from several new sites across the USA and around the world. Late-breaking clinical data with a focus on promising new technologies will also be featured.
In response to the popularity of the “Deep Dive” sessions, the program will now feature dedicated tracks with interactive sessions woven throughout the course of the meeting. These tracks will be focused on critically relevant topics, including Peripheral Artery Disease, Critical Limb Ischemia, Complex Aortic and Iliac Interventions, Clot Management, Venous Interventions, and Embolotherapy.
Created in 1989 by Barry T Katzen (Miami Cardiac and Vascular Institute, Miami, USA), the founder and chief medical executive of Miami Cardiac & Vascular Institute, ISET is the premier educational forum for physicians and allied health professionals who treat patients with peripheral, cardiac, and neurovascular disease. The annual meeting, which features globally recognised faculty who are experts in their field, draws more than 800 attendees from around the world and delivers practical and hands-on education focused on the latest endovascular approaches, techniques, and technologies.
Katzen comments: “For three decades we have been providing clinicians with premier endovascular education. Innovative thinking, determination, and dedication to excellence are hallmarks of our great field, and we recognise that clinician education must continually change as the needs of patients and the healthcare landscape change. Together with my fellow course directors, we have enhanced ISET in response to the needs of our participants, and we believe the new investments we have made and the new approaches we are taking will yield the strongest ISET program yet. We look forward to delivering relevant, real-world endovascular education with a uniquely personal and interactive approach led by globally recognised faculty to a multidisciplinary audience in 2019.”
